牛叉诊股

[{"date":"2026.06.01","stock":"-0.39","trade":"1.32","ind":"-0.27"},{"date":"2026.05.29","stock":"2.06","trade":"1.30","ind":"-0.73"},{"date":"2026.05.28","stock":"-1.86","trade":"-0.70","ind":"0.12"},{"date":"2026.05.27","stock":"4.46","trade":"-0.49","ind":"-1.25"},{"date":"2026.05.26","stock":"0.24","trade":"-1.00","ind":"-0.17"},{"date":"2026.05.25","stock":"1.07","trade":"-0.47","ind":"0.96"},{"date":"2026.05.22","stock":"-2.01","trade":"0.56","ind":"0.87"},{"date":"2026.05.21","stock":"-0.40","trade":"-1.85","ind":"-2.04"},{"date":"2026.05.20","stock":"-2.04","trade":"-0.72","ind":"-0.18"},{"date":"2026.05.19","stock":"-0.62","trade":"0.64","ind":"0.92"},{"date":"2026.05.18","stock":"-2.44","trade":"-0.90","ind":"-0.09"},{"date":"2026.05.15","stock":"0.61","trade":"-0.91","ind":"-1.02"},{"date":"2026.05.14","stock":"-1.58","trade":"-1.27","ind":"-1.52"},{"date":"2026.05.13","stock":"-1.04","trade":"-0.26","ind":"0.67"},{"date":"2026.05.12","stock":"-2.26","trade":"-1.60","ind":"-0.25"},{"date":"2026.05.11","stock":"0.51","trade":"0.72","ind":"1.08"},{"date":"2026.05.08","stock":"1.56","trade":"0.79","ind":"-0.00"},{"date":"2026.05.07","stock":"0.07","trade":"-0.27","ind":"0.48"},{"date":"2026.05.06","stock":"-0.37","trade":"-0.14","ind":"1.17"},{"date":"2026.04.30","stock":"-3.37","trade":"0.43","ind":"0.11"},{"date":"2026.04.29","stock":"0.14","trade":"0.63","ind":"0.71"}]

康缘药业,上证指数,中药指数

压力支撑

该股压力位为12.83元，支撑位为12.68元。

[{"text":"\u538b\u529b\u4f4d","value":"12.83","date":1780243200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"12.68","date":1780243200,"color":"0x0b52a1"}]

多空趋势

空头行情中，目前反弹趋势有所减缓，投资者可适当关注。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：4.0资金面打败了43%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

中药行业，近5日资金总体无进出。

更新时间：06月02日 12:31

机构今日流向(万元)	455.00	机构5日流向(万元)	-465.35
机构10日流向(万元)	-3903.89	机构20日流向(万元)	-15323.15

机构持仓

2025-12-31 与 2025-06-30 相比，主力机构持仓量减少3959.77万股，其中基金净减仓9家，主力净减仓80家，请投资者中长期谨慎为宜。

截止2025-12-31，共85家主力机构（基金81家，一般法人4家），持仓量总计25808.3万股，占流通A股45.58%
其中，基金持仓与2025-06-30相比：
增仓：12家，增持 212.97万股
减仓：21家，减持 222.14万股
新出现在主力名单中：33家，持有403.96万股
从主力名单中消失：113家，原持有4450.75万股

消息面诊股

诊断结果：5.5消息面打败了47%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	分红转增	不分配不转增	2026-04-23
一般消息	重大事项	关联交易	2025-12-30
一般消息	高管变动	取消监事会	2025-12-29
一般消息	股东大会	临时股东大会	2025-12-12
一般消息	重大事项	关联交易	2025-12-12
一般消息	高管变动	工作调整	2025-12-09
一般消息	重大事项	公司股东股份解押	2025-09-27
一般消息	分红转增	不分配不转增	2025-08-28
一般消息	高管变动	因个人原因	2025-06-20

一年消息统计

	所有消息	重大消息	非重大消息
利好	0条	0条	0条
利空	0条	0条	0条

行业面诊股

诊断结果：6.5行业面打败了94%的股票中药行业最新资金流向

近10日来该行业走势不明显，接近大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，接近大盘。

[{"date":"2026.06.01","price":"-0.27","value":"1.32"},{"date":"2026.05.29","price":"-0.73","value":"1.30"},{"date":"2026.05.28","price":"0.12","value":"-0.70"},{"date":"2026.05.27","price":"-1.25","value":"-0.49"},{"date":"2026.05.26","price":"-0.17","value":"-1.00"},{"date":"2026.05.25","price":"0.96","value":"-0.47"},{"date":"2026.05.22","price":"0.87","value":"0.56"},{"date":"2026.05.21","price":"-2.04","value":"-1.85"},{"date":"2026.05.20","price":"-0.18","value":"-0.72"},{"date":"2026.05.19","price":"0.92","value":"0.64"},{"date":"2026.05.18","price":"-0.09","value":"-0.90"},{"date":"2026.05.15","price":"-1.02","value":"-0.91"},{"date":"2026.05.14","price":"-1.52","value":"-1.27"},{"date":"2026.05.13","price":"0.67","value":"-0.26"},{"date":"2026.05.12","price":"-0.25","value":"-1.60"},{"date":"2026.05.11","price":"1.08","value":"0.72"},{"date":"2026.05.08","price":"-0.00","value":"0.79"},{"date":"2026.05.07","price":"0.48","value":"-0.27"},{"date":"2026.05.06","price":"1.17","value":"-0.14"},{"date":"2026.04.30","price":"0.11","value":"0.43"},{"date":"2026.04.29","price":"0.71","value":"0.63"}]

上证指数,中药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	三力制药	47.67%	11.86%	6.8分
2	粤万年青	36.97%	-4.78%	5.6分
3	众生药业	27.06%	-1.49%	6.1分
4	太龙药业	13.66%	1.40%	6.0分
5	维康药业	12.00%	-8.39%	5.0分
6	华润江中	7.92%	13.51%	6.5分
7	珍宝岛	7.80%	-9.10%	5.4分
8	*ST香雪	4.14%	0.51%	4.2分
9	康惠股份	3.32%	-1.83%	5.2分
10	济川药业	0.76%	-3.88%	6.6分
11	达仁堂	0.33%	0.35%	4.7分
12	ST葫芦娃	0.00%	-3.13%	5.5分
13	昆药集团	-0.32%	13.28%	5.9分
14	葵花药业	-0.69%	0.08%	5.2分
15	汉森制药	-2.00%	1.63%	4.8分
16	精华制药	-2.08%	2.91%	5.5分
17	羚锐制药	-2.93%	3.16%	5.9分
18	盘龙药业	-3.23%	0.76%	3.9分
19	-	-3.36%	-0.41%	分
20	桂林三金	-3.58%	1.63%	5.5分
21	华润三九	-3.73%	2.98%	6.6分
22	红日药业	-4.08%	0.92%	5.3分
23	华神科技	-4.58%	-7.69%	4.4分
24	佛慈制药	-4.62%	2.75%	6.0分
25	恩威医药	-4.68%	-12.07%	5.3分
26	康恩贝	-4.70%	0.00%	6.1分
27	仁和药业	-4.74%	0.37%	5.2分
28	同仁堂	-4.93%	3.13%	5.1分
29	信邦制药	-4.94%	0.00%	5.4分
30	天士力	-4.97%	2.50%	5.7分
31	白云山	-5.07%	1.02%	5.3分
32	上海凯宝	-5.59%	0.00%	4.5分
33	佐力药业	-5.84%	3.80%	5.7分
34	古汉医药	-5.95%	1.06%	6.0分
35	以岭药业	-5.95%	-0.13%	5.4分
36	云南白药	-6.09%	0.71%	5.4分
37	方盛制药	-6.19%	0.40%	5.6分
38	奇正藏药	-6.40%	-1.66%	4.9分
39	千金药业	-6.59%	0.29%	6.1分
40	亚宝药业	-6.65%	1.10%	5.4分
41	太极集团	-6.68%	0.55%	5.3分
42	东阿阿胶	-6.84%	3.13%	5.5分
43	吉林敖东	-6.91%	-0.40%	5.0分
44	马应龙	-6.97%	1.63%	5.4分
45	ST百灵	-7.09%	1.72%	4.5分
46	健民集团	-7.37%	-5.08%	5.3分
47	片仔癀	-7.47%	3.99%	5.7分
48	康缘药业	-7.81%	4.47%	5.8分
49	步长制药	-8.18%	-0.92%	5.1分
50	中恒集团	-8.40%	2.23%	5.3分
51	-	-9.20%	0.41%	分
52	天目药业	-9.27%	-3.94%	4.5分
53	新天药业	-9.50%	-3.80%	4.0分
54	寿仙谷	-9.62%	-2.35%	4.9分
55	新光药业	-10.07%	-2.26%	4.0分
56	华森制药	-10.12%	-0.16%	5.2分
57	特一药业	-10.37%	-0.11%	4.5分
58	康美药业	-10.40%	-1.27%	4.5分
59	广誉远	-10.71%	1.28%	4.7分
60	振东制药	-10.80%	-2.85%	4.3分
61	益佰制药	-11.17%	-1.08%	4.8分
62	益盛药业	-11.45%	-4.34%	4.8分
63	九芝堂	-12.50%	0.85%	5.7分
64	沃华医药	-12.86%	-1.94%	5.3分
65	陇神戎发	-13.54%	-3.31%	4.4分
66	ST金花	-28.55%	3.99%	5.0分
67	ST嘉应	-37.46%	5.76%	4.8分
68	ST万邦	-46.48%	14.48%	5.6分

<上一页 1 2 3 4 5...12 下一页>

行业评级

最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

综合评级

研究机构	评级日期	最新评级	上次评级
中信证券	2012-09-10	增持	增持
招商证券	2012-09-08	增持	增持
航天证券	2012-09-06	增持	-
中银国际	2012-09-05	增持	-
齐鲁证券	2012-09-05	增持	-

基本面诊股

诊断结果：6.3基本面打败了66%的股票连续3年业绩增长30%的公司

该公司运营状况尚可，多数机构认为该股长期投资价值较高，投资者可加强关注。

个股深一度

潜在高分红能力：中（87.5分）

基本面得分最高的股票

[ 截止日期：2026-03-31 ]公司经营

盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 40/107 ， 13/107。

[{"date":"2026-03-31","value":"1.63","vol":"2.21"},{"date":"2025-12-31","value":"6.51","vol":"-2.33"},{"date":"2025-09-30","value":"4.33","vol":"4.80"},{"date":"2025-06-30","value":"3.10","vol":"4.03"},{"date":"2025-03-31","value":"1.83","vol":"2.24"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净资产收益率(%)	1.63	6.51	4.33	3.10	1.83
行业(%)	2.21	-2.33	4.80	4.03	2.24

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"74.97","vol":"55.05"},{"date":"2025-12-31","value":"71.44","vol":"52.85"},{"date":"2025-09-30","value":"69.47","vol":"53.29"},{"date":"2025-06-30","value":"70.88","vol":"53.82"},{"date":"2025-03-31","value":"74.18","vol":"54.48"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
销售毛利率(%)	74.97	71.44	69.47	70.88	74.18
行业(%)	55.05	52.85	53.29	53.82	54.48

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 34/107 ， 42/107。

[{"date":"2026-03-31","value":"-5.27","vol":"-5.58"},{"date":"2025-12-31","value":"-15.52","vol":"-6.76"},{"date":"2025-09-30","value":"-24.59","vol":"-7.84"},{"date":"2025-06-30","value":"-27.29","vol":"-7.78"},{"date":"2025-03-31","value":"-35.38","vol":"-7.40"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
营业收入同比增长率(%)	-5.27	-15.52	-24.59	-27.29	-35.38
行业(%)	-5.58	-6.76	-7.84	-7.78	-7.40

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"-4.96","vol":"1.06"},{"date":"2025-12-31","value":"-22.44","vol":"-80.25"},{"date":"2025-09-30","value":"-35.63","vol":"-2.78"},{"date":"2025-06-30","value":"-40.12","vol":"2.25"},{"date":"2025-03-31","value":"-38.37","vol":"-37.69"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净利润同比增长率(%)	-4.96	-22.44	-35.63	-40.12	-38.37
行业(%)	1.06	-80.25	-2.78	2.25	-37.69

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 34/107 ， 39/107。

[{"date":"2026-03-31","value":"0.12","vol":"0.12"},{"date":"2025-12-31","value":"0.48","vol":"0.47"},{"date":"2025-09-30","value":"0.34","vol":"0.35"},{"date":"2025-06-30","value":"0.24","vol":"0.24"},{"date":"2025-03-31","value":"0.13","vol":"0.13"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
总资产周转率(次)	0.12	0.48	0.34	0.24	0.13
行业(次)	0.12	0.47	0.35	0.24	0.13

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.46","vol":"0.59"},{"date":"2025-12-31","value":"1.89","vol":"2.34"},{"date":"2025-09-30","value":"1.45","vol":"1.72"},{"date":"2025-06-30","value":"0.96","vol":"1.17"},{"date":"2025-03-31","value":"0.43","vol":"0.59"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
存货增长率(次)	0.46	1.89	1.45	0.96	0.43
行业(次)	0.59	2.34	1.72	1.17	0.59

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2026-03-31","value":"7.93","vol":"5.83"},{"date":"2025-12-31","value":"27.83","vol":"30.77"},{"date":"2025-09-30","value":"28.78","vol":"10.53"},{"date":"2025-06-30","value":"8.82","vol":"22.82"},{"date":"2025-03-31","value":"8.77","vol":"2.06"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
现金流量净额/营业收入	7.93	27.83	28.78	8.82	8.77
行业	5.83	30.77	10.53	22.82	2.06

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"2.63","vol":"1.00"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"2.10","vol":"1.03"},{"date":"2025-03-31","value":"","vol":"0.00"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资本支出／折旧和摊销	-	2.63	-	2.10	-
行业	0.00	1.00	0.00	1.03	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 6/107 ， 30/107。

[{"date":"2026-03-31","value":"1.93","vol":"2.97"},{"date":"2025-12-31","value":"1.92","vol":"2.94"},{"date":"2025-09-30","value":"2.00","vol":"3.09"},{"date":"2025-06-30","value":"1.93","vol":"2.94"},{"date":"2025-03-31","value":"1.82","vol":"3.03"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
流动比率	1.93	1.92	2.00	1.93	1.82
行业	2.97	2.94	3.09	2.94	3.03

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"1.61","vol":"2.23"},{"date":"2025-12-31","value":"1.60","vol":"2.15"},{"date":"2025-09-30","value":"1.69","vol":"2.24"},{"date":"2025-06-30","value":"1.62","vol":"2.15"},{"date":"2025-03-31","value":"1.50","vol":"2.24"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
速动比率	1.61	1.60	1.69	1.62	1.50
行业	2.23	2.15	2.24	2.15	2.24

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 34/107 ， 37/107。

[{"date":"2026-03-31","value":"26.06","vol":"31.94"},{"date":"2025-12-31","value":"26.96","vol":"32.43"},{"date":"2025-09-30","value":"27.11","vol":"31.59"},{"date":"2025-06-30","value":"28.97","vol":"32.45"},{"date":"2025-03-31","value":"30.42","vol":"31.91"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资产负债率(%)	26.06	26.96	27.11	28.97	30.42
行业(%)	31.94	32.43	31.59	32.45	31.91

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.37","vol":"0.66"},{"date":"2025-12-31","value":"0.38","vol":"0.67"},{"date":"2025-09-30","value":"0.39","vol":"0.76"},{"date":"2025-06-30","value":"0.43","vol":"0.75"},{"date":"2025-03-31","value":"0.46","vol":"0.74"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
产权比率 (%)	0.37	0.38	0.39	0.43	0.46
行业(%)	0.66	0.67	0.76	0.75	0.74

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。

研究机构	评级日期	最新评级	上次评级
华泰证券	2026-05-14	买入	买入
长城证券	2026-05-08	买入
东北证券	2026-04-27	增持

机构预测

机构预测该股2026年每股收益与前一年相同，长期投资价值一般。

[{"date":"2022","yellowRectValue":"4.34","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"4.64","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"3.92","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"3.04","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"3.44","blueLineValue":"0.61","type":"YC"}]

[康缘药业]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]